Press contact
Communication Service
Phone: +33(0) 362 263 772
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Our press releases
GenoScreen and Illumina Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis
Deeplex® Myc-TB: Pursue the global deployment of the innovative solution for predicting antibiotic resistance in tuberculosis
Deeplex® Myc-TB, a breakthrough innovation to effectively fight tuberculosis
A microbial signature in indoor air associated with severe asthma
Number of new cases in contacts of leprosy patients decreases after dose of antibiotic
Publication of the first comprehensive performance evaluation of the "Deeplex® Myc-TB" test for the prediction of tuberculosis antibiotic resistance
Tuberculosis: discovery of an ancestral lineage in the African Great Lakes region
GenoScreen launches a rapid, effective diagnostic kit, to combat tuberculosis antibiotic resistance
(French) Grippe : lutter contre les surinfections bactériennes grâce au microbiote
A major advance in the fight against multidrug-resistant tuberculosis
GenoScreen in the news
04/12/2023
GlobeNewswire - Global Biotechnology Instruments Market Size To Exceed USD 152.5 Billion by 2032 | CAGR of 8.1%
11/2023
WHO - Global Tuberculosis Report
09/2023
Institut Pasteur - 2022 Annual Report
08/2023
Market.us - Pharmacogenomics Market
07/2023
Medical Device Network - Illumina and Pillar collaborate to commercialise oncology assays
03/2023
Medtech Alert - Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa
05/01/2023
360dx - COVID-19 Still a Focus for Infectious Disease Test Developers in 2022, but Ceded Some Ground